Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis
<h4>Background</h4> Long non-coding RNAs (lncRNAs) have been reported to be involved in the pathogenesis of neurodegenerative diseases. It has also been hypothesized that plasma exosomal lncRNAs may be used as Alzheimer’s disease (AD) biomarkers. In this systematic review, we compiled al...
Main Authors: | Parnian Shobeiri, Sanam Alilou, Mehran Jaberinezhad, Farshad Zare, Nastaran Karimi, Saba Maleki, Antonio L. Teixeira, George Perry, Nima Rezaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032479/?tool=EBI |
Similar Items
-
Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
by: Parnian Shobeiri, et al.
Published: (2023-01-01) -
Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis
by: Amirali Karimi, et al.
Published: (2021-10-01) -
Role of long non‐coding RNAs in cholangiocarcinoma: A systematic review and meta‐analysis
by: Parnian Shobeiri, et al.
Published: (2024-03-01) -
Blood levels of brain-derived neurotrophic factor (BDNF) in systemic lupus erythematous (SLE): a systematic review and meta-analysis
by: Parnian Shobeiri, et al.
Published: (2023-03-01) -
A systematic review of ECG findings in patients with COVID-19
by: Esmaeil Mehraeen, et al.
Published: (2020-11-01)